![](https://www.diabetesnews.com/wp-content/uploads/2016/07/medical-marijuana_custom-1f2a70282ad65284fa1cd26af7ea910ae9d47503-s700-c85-150x150.jpg)
Research published Wednesday found that states that legalized medical marijuana — which is sometimes recommended for symptoms like chronic pain, anxiety or depression — saw declines in the number of Medicare prescriptions for drugs used to treat those conditions and a dip in spending by Medicare Part D, which covers the cost on prescription medications.